(Q31925615)

5 July 2017

title

Mixed pharmacokinetic population study and diffusion model to describe ciprofloxacin lung concentrations (English)

1 reference

5 July 2017

1 reference

Breilh D

1

1 reference

5 July 2017

Saux MC

2

1 reference

5 July 2017

Maire P

3

1 reference

5 July 2017

Vergnaud JM

4

1 reference

5 July 2017

Jelliffe RW

5

1 reference

5 July 2017

publication date

1 May 2001

1 reference

Computers in Biology and Medicine

5 July 2017

published in

1 reference

5 July 2017

volume

31

1 reference

5 July 2017

issue

3

1 reference

5 July 2017

page(s)

147-155

1 reference

Comparative study of pharmacokinetics and serum bactericidal activities of cefpirome, ceftazidime, ceftriaxone, imipenem, and ciprofloxacin

5 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0010-4825%2800%2900031-7

Pharmacokinetics of ciprofloxacin after oral and parenteral administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-4825%2800%2900031-7

Comparative pharmacokinetics and safety of ciprofloxacin 400 mg i.v. thrice daily versus 750 mg po twice daily

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-4825%2800%2900031-7

Increased oral bioavailability of ciprofloxacin in cystic fibrosis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-4825%2800%2900031-7

Extravascular penetration of ciprofloxacin. A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-4825%2800%2900031-7

Pharmacokinetics and tissue penetration of ciprofloxacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-4825%2800%2900031-7

Tissue penetration of ciprofloxacin after single and multiple doses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-4825%2800%2900031-7

The penetration of ciprofloxacin into bronchial mucosa, lung parenchyma, and pleural tissue after intravenous administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-4825%2800%2900031-7

Penetration of ciprofloxacin and metabolites into human lung, bronchial and pleural tissue after 250 and 500 mg oral ciprofloxacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-4825%2800%2900031-7

Concentration of ciprofloxacin in human serum, lung and pleural tissues and fluids during and after lung surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-4825%2800%2900031-7

Penetration of pefloxacin and ciprofloxacin into lung tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-4825%2800%2900031-7

Comparative pharmacokinetic disposition of fluoroquinolones in the lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-4825%2800%2900031-7

Pharmacokinetics of four fluoroquinolones in an animal model of infected lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-4825%2800%2900031-7

Comparative penetration of selected fluoroquinolones into respiratory tract fluids and tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-4825%2800%2900031-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0010-4825(00)00031-7

1 reference

journals/cbm/BreilhSMVJ01

5 July 2017

DBLP publication ID

1 reference

DBLP Dataset 2021-01-02

28 January 2021

1 reference